Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with heart failure who have mitral regurgitation due to left ventricular dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their clinical outcomes. METHODS: At 78 sites in the United States and Canada, we enrolled patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy. Patients were randomly assigned to transcatheter mitral-valve repair plus medical therapy (device group) or medical therapy alone (control group). The primary effectiveness end point was all hospitalizations for heart failure within 24 months of follow-up. The primary safety end point was freedom from device-related complications at 12 months; the rate for this end point was compared with a prespecified objective performance goal of 88.0%. RESULTS: Of the 614 patients who were enrolled in the trial, 302 were assigned to the device group and 312 to the control group. The annualized rate of all hospitalizations for heart failure within 24 months was 35.8% per patient-year in the device group as compared with 67.9% per patient-year in the control group (hazard ratio, 0.53; 95% confidence interval [CI], 0.40 to 0.70; P<0.001). The rate of freedom from device-related complications at 12 months was 96.6% (lower 95% confidence limit, 94.8%; P<0.001 for comparison with the performance goal). Death from any cause within 24 months occurred in 29.1% of the patients in the device group as compared with 46.1% in the control group (hazard ratio, 0.62; 95% CI, 0.46 to 0.82; P<0.001). CONCLUSIONS: Among patients with heart failure and moderate-to-severe or severe secondary mitral regurgitation who remained symptomatic despite the use of maximal doses of guideline-directed medical therapy, transcatheter mitral-valve repair resulted in a lower rate of hospitalization for heart failure and lower all-cause mortality within 24 months of follow-up than medical therapy alone. The rate of freedom from device-related complications exceeded a prespecified safety threshold. (Funded by Abbott; COAPT ClinicalTrials.gov number, NCT01626079 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The magnitude of the tirzepatide-mediated improvement in the win ratio was large and similar to the effect of transcatheter mitral valve repair in patients with HF and secondary mitral regurgitation.32”
From Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity (2025) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx391 · Cited by 6,243
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Self-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Self-citationNishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Self-citationPercutaneous Repair or Surgery for Mitral Regurgitation
Feldman, T., Foster, E., Glower, D. D., Kar, S., Rinaldi, M. J., Fail, P. S., Smalling, R. W., Siegel, R., Rose, G. A., Engeron, E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009355 · Cited by 2,183
Self-citationThe prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Self-citationPercutaneous Mitral Valve Interventions in the Real World
Maisano, F., Franzen, O., Baldus, S., Schäfer, U., Hausleiter, J., Butter, C., Ussia, G. P., Sievert, H., Richardt, G., Widder, J. D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.094 · Cited by 839
Stone, G. W., Adams, D. H., Abraham, W. T., Kappetein, A. P., Généreux, P., Vranckx, P., Mehran, R., Kuck, K.-H., Leon, M. B., Piazza, N., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.049 · Cited by 594
Self-citationSecondary Mitral Regurgitation in Heart Failure
Asgar, A. W., Mack, M. J., & Stone, G. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.009 · Cited by 489
Self-citation
Research works printed but not linked: 1
- 16. cancer events. Biostatistics 2007; 8: 70821.
Cited by
Items 101–200 of 1,001
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 167
Karam, N., Stolz, L., Orban, M., Deseive, S., Praz, F., Kalbacher, D., Westermann, D., Braun, D., Näbauer, M., Neuß, M., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.12.015 · Cited by 136
JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies
Kitaoka, H., Tsutsui, H., Kubo, T., Ide, T., Chikamori, T., Fukuda, K., Fujino, N., Higo, T., Isobe, M., Kamiya, C., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-20-0910 · Cited by 134
Impact of Tricuspid Regurgitation on Clinical Outcomes
Hahn, R. T., Asch, F. M., Weissman, N. J., Grayburn, P. A., Kar, S., Lim, S., Ben‐Yehuda, O., Shahim, B., Chen, S., Liu, M., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.035 · Cited by 132
Self-citationTranscatheter Mitral Valve Repair in Patients With Atrial Functional Mitral Regurgitation
Doldi, P. M., Stolz, L., Orban, M., Karam, N., Praz, F., Kalbacher, D., Lubos, E., Braun, D., Adamo, M., Giannini, C., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.05.009 · Cited by 132
The win ratio in cardiology trials: lessons learnt, new developments, and wise future use
Pocock, S., Gregson, J., Collier, T. J., Ferreira, J. P., & Stone, G. W. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae647 · Cited by 133
“…clinical hierarchy includes not only deaths and non-fatal events but also other measures of patient well-being, measures of physical 11 ( B ) COAPT, 12 and ( C ) EMPEROR-Preserved 6 ) of a two-level hierarchy win ratio analysis for a hierarchical composite of time to death and then time to a…”
InfluentialSelf-citationGodino, C., Munafò, A. R., Scotti, A., Estévez‐Loureiro, R., Hernàndez, A. P., Arzamendi, D., Fernández‐Peregrina, E., Taramasso, M., Fam, N., Ho, E. C., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.09.005 · Cited by 131
Bakaeen, F. G., Gaudino, M. F. L., Whitman, G. R., Doenst, T., Ruel, M., Taggart, D. P., Stulak, J. M., Benedetto, U., Anyanwu, A., Chikwe, J., et al. (2021) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.052 · Cited by 133
Adamo, M., Fiorelli, F., Melica, B., D’Ortona, R., Lupi, L., Giannini, C., Silva, G. S., Fiorina, C., Branca, L., Chiari, E., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.050 · Cited by 128
Kar, S., Mack, M. J., Lindenfeld, J., Abraham, W. T., Asch, F. M., Weissman, N. J., Enriquez-Sarano, M. L., Lim, D. S., Mishell, J. M., Whisenant, B. K., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.053061 · Cited by 128
Self-citationUpdate on heart failure management and future directions
Choi, H., Park, M., & Youn, J. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.428 · Cited by 126
“On the other hand, in the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial performed in 614 symptomatic patients with HF and moderate-to-severe secondary MR despite maximal medical therapy, the addition of percutaneou…”
MethodA Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation
Bartko, P. E., Arfsten, H., Heitzinger, G., Pávó, N., Toma, A., Strunk, G., Hengstenberg, C., Hülsmann, M., & Goliasch, G. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.075 · Cited by 126
“IV 49 (12) 16 (8) 13 (6) 20 (20) Creatinine, mg/dl 1.”
ResultPacker, M., & Grayburn, P. A. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2019.5971 · Cited by 125
Self-citationCombined Tricuspid and Mitral Versus Isolated Mitral Valve Repair for Severe MR and TR
Mehr, M., Karam, N., Taramasso, M., Ouarrak, T., Schneider, S., Lurz, P. C., von Bardeleben, R. S., Fam, N., Pozzoli, A., Lubos, E., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.10.023 · Cited by 123
A Score to Assess Mortality After Percutaneous Mitral Valve Repair
Raposeiras‐Roubín, S., Adamo, M., Freixa, X., Arzamendi, D., Benito‐González, T., Montefusco, A., Pascual, I., y, L. N.-F., Rodés‐Cabau, J., Shuvy, M., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.11.041 · Cited by 123
O’Meara, E., McDonald, M., Chan, M., Ducharme, A., Ezekowitz, J. A., Giannetti, N., Grzeslo, A., Heckman, G. A., Howlett, J. G., Koshman, S. L., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.11.036 · Cited by 122
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study
Webb, J. G., Hensey, M., Szerlip, M., Schäfer, U., Cohen, G. N., Kar, S., Makkar, R., Kipperman, R., Spargias, K. S., O’Neill, W. W., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.019 · Cited by 122
“The COAPT trial examined the use of the MitraClip system in patients with severe FMR (10).”
BackgroundMethodSelf-citationTranscatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System
Chakravarty, T., Makar, M. M., Patel, D., Oakley, L. S., Yoon, S. H., Stegic, J., Singh, S., Skaf, S., Nakamura, M., & Makkar, R. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.06.053 · Cited by 119
Transcatheter Mitral Valve Replacement
Hensey, M., Brown, R. A., Lal, S., Sathananthan, J., Ye, J., Cheung, A., Blanke, P., Leipsic, J. A., Moss, R., Boone, R. H., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.12.038 · Cited by 120
Mieghem, N. M. V., Elmariah, S., Spitzer, E., Pîbarot, P., Nazif, T. M., Bax, J. J., Hahn, R. T., Popma, A., Ben‐Yehuda, O., Kallel, F., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.10.070 · Cited by 120
Self-citationEarly Experience With Transcatheter Mitral Valve Replacement: A Systematic Review
del Val, D., Ferreira‐Neto, A. N., Wintzer-Wehekind, J., Dagenais, F., Paradis, J., Bernier, M., O’Connor, K., Beaudoin, J., Freitas‐Ferraz, A. B., & Rodés‐Cabau, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013332 · Cited by 117
“However, the COAPT (Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy) trial demonstrated significantly lower all-cause mortality and rehospitalization for heart failure in patients who underwent the MitraClip procedure.(34) Main patient baseline characteristic and results comparing the TMVR populatio…”
ResultEdge-to-Edge Mitral Valve Repair With Extended Clip Arms
Praz, F., Braun, D., Unterhuber, M., Spirito, A., Orban, M., Brugger, N., Brinkmann, I., Spring, K., Moschovitis, A., Näbauer, M., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.03.023 · Cited by 116
Right Ventricular–Pulmonary Arterial Coupling in Patients With HF Secondary MR
Brener, M. I., Grayburn, P. A., Lindenfeld, J. M., Burkhoff, D., Liu, M., Zhou, Z., Alu, M. C., Medvedofsky, D. A., Asch, F. M., Weissman, N. J., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.07.047 · Cited by 115
Self-citationContemporary Outcomes Following Transcatheter Edge-to-Edge Repair
Kar, S., von Bardeleben, R. S., Rottbauer, W., Mahoney, P. D., Price, M. J., Grasso, C., Williams, M. R., Lurz, P. C., Ahmed, M. I., Hausleiter, J., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.01.010 · Cited by 115
Self-citationSenni, M., Adamo, M., Metra, M., Alfieri, O., & Vahanian, A. S. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1491 · Cited by 113
1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation
Zahr, F. E., Smith, R. L., Gillam, L. D., Chadderdon, S. M., Makkar, R., von Bardeleben, R. S., Ruf, T. F., Kipperman, R., Rassi, A. N., Szerlip, M., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.10.002 · Cited by 113
Self-citationDonal, E., Delgado, V., Bucciarelli‐Ducci, C., Galli, E., Haugaa, K. H., Charron, P., Voigt, J., Cardim, N. M., Masci, P. G., Galderisi, M., et al. (2019) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jez178 · Cited by 112
Current Status and Future Prospects of Transcatheter Mitral Valve Replacement
Alperi, A., Granada, J. F., Bernier, M., Dagenais, F., & Rodés‐Cabau, J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.051 · Cited by 112
Unmet needs in valvular heart disease
Messika–Zeitoun, D., Baumgartner, H., Burwash, I. G., Vahanian, A. S., Bax, J. J., Pîbarot, P., Chan, V., Leon, M. B., Enriquez-Sarano, M. L., Mesana, T. G., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad121 · Cited by 112
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation
Jung, R. G., Simard, T., Kovach, C. P., Flint, K. M., Don, C. W., Santo, P. D., Adamo, M., Branca, L., Valentini, F., Benito‐González, T., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.08.037 · Cited by 110
Cavalcante, J. L., Kusunose, K., Obuchowski, N. A., Jellis, C. L., Griffin, B. P., Flamm, S. D., & Kwon, D. H. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.11.008 · Cited by 109
Valvular heart disease: from mechanisms to management
Praz, F., Beyersdorf, F., Haugaa, K. H., & Prendergast, B. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02755-1 · Cited by 108
Namazi, F., van der Bijl, P., Hirasawa, K., Kamperidis, V., van Wijngaarden, S. E., Mertens, B. J. A., Leon, M. B., Hahn, R. T., Stone, G. W., Narula, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.024 · Cited by 106
“Two randomized trials, evaluating the prognostic effect of transcatheter mitral valve treatment in patients with secondary MR, were recently published (1,2).”
BackgroundMethodSelf-citationOrban, M., Rommel, K., Ho, E. C., Unterhuber, M., Pozzoli, A., Connelly, K. A., Deseive, S., Besler, C., Ong, G., Braun, D., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.12.006 · Cited by 106
Myocardial Work: Methodology and Clinical Applications
Papadopoulos, K. G., Tok, Ö. Ö., Mitrousi, K., & Ikonomidis, I. (2021) · Diagnostics · doi:10.3390/diagnostics11030573 · Cited by 105
2025 ESC/EACTS Guidelines for the management of valvular heart disease
Praz, F., Borger, M. A., Lanz, J., Cuartas, M. M., Abreu, A., Adamo, M., Marsan, N. A., Barili, F., Bonaros, N. E., Cosyns, B., et al. (2025) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaf276 · Cited by 107
Cabac‐Pogorevici, I., Muk, B., Rustamova, Y., Kalogeropoulos, A. S., Tzeis, S. E., & Vardas, P. E. (2020) · European Journal of Heart Failure · doi:10.1002/ejhf.1747 · Cited by 102
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Crestanello, J. A., Oh, J. K., & Schaff, H. V. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1903982 · Cited by 100
Varma, N., BOEHMER, J. P., Bhargava, K., Yoo, D., Leonelli, F. M., Costanzo, M.-R., Saxena, A., Sun, L., Gold, M. R., Singh, J. P., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.043 · Cited by 99
Bartko, P. E., Heitzinger, G., Pávó, N., Heitzinger, M., Spinka, G., Prausmüller, S., Arfsten, H., Andreas, M., Gabler, C., Strunk, G., et al. (2021) · BMJ · doi:10.1136/bmj.n1421 · Cited by 99
Complications Following MitraClip Implantation
Schnitzler, K., Hell, M. M., Geyer, M., Kreidel, F., Münzel, T. F., & von Bardeleben, R. S. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01553-9 · Cited by 99
Sugiura, A., Kavsur, R., Spieker, M., Iliadis, C., Goto, T., Öztürk, C., Weber, M., Tabata, N., Zimmer, S., Sinning, J.-M., et al. (2022) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.121.010895 · Cited by 99
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy
Howlett, J. G., Stebbins, A., Petrie, M. C., Jhund, P. S., Castelvecchio, S., Cherniavsky, A., Sueta, C. A., Roy, A., Piña, I. L., Wurm, R., et al. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.04.018 · Cited by 97
“Cardiac resynchronization therapy, eplerenone, and sacubitril/valsartan confer a reduction in recurrent hospitalization in addition to the demonstrated benefits using time-to-first-event analysis (6,10,17-19).”
BackgroundMethodReoperative Cardiac Surgery Is a Risk Factor for Long-Term Mortality
Bianco, V. J., Kilic, A., Gleason, T. G., Aranda-Michel, E. C., Habertheuer, A., Wang, Y., Navid, F., Kacin, A. J., & Sultan, I. S. (2020) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2020.02.028 · Cited by 96
Hypoalbuminaemia and Heart Failure: A Practical Review of Current Evidence
Biancucci, M., Barbiero, R., Pennella, B., Cannata, A. N., Ageno, W., Tangianu, F., Maresca, A. M., Dentali, F., & Bonaventura, A. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3363 · Cited by 97
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure
Newman, J. D., O’Meara, E., Böhm, M., Savarese, G., Kelly, P. R., Vardeny, O., Allen, L. A., Lancellotti, P., Gottlieb, S. S., Samad, Z. Z., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.033 · Cited by 96
Self-citationDevice Therapy in Chronic Heart Failure
Fudim, M., Abraham, W. T., von Bardeleben, R. S., Lindenfeld, J. M., Ponikowski, P. P., Salah, H. M., Khan, M. S., Sievert, H., Stone, G. W., Anker, S. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.040 · Cited by 93
Self-citationSimard, T., Vemulapalli, S., Jung, R. G., Vekstein, A. M., Stebbins, A., Holmes, D. R., Czarnecki, A., Hibbert, B. M., & Alkhouli, M. A. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.09.006 · Cited by 92
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
Liga, R., Colli, A., Taggart, D. P., Boden, W. E., & Caterina, R. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026943 · Cited by 93
Transcatheter treatment of the tricuspid valve: current status and perspectives
Maisano, F., Hahn, R., Sorajja, P., Praz, F., & Lurz, P. C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae082 · Cited by 92
Natriuretic Peptides as Inclusion Criteria in Clinical Trials
Ibrahim, N. E., Burnett, J. C., Butler, J., Camacho, A., Felker, G. M., Fiuzat, M., O’Connor, C., Solomon, S. D., Vaduganathan, M., Zile, M. R., et al. (2020) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.12.010 · Cited by 83
Lindenfeld, J. M., Abraham, W. T., Grayburn, P. A., Kar, S., Asch, F. M., Lim, D. S., Nie, H., Singhal, P., Sundareswaran, K. S., Weissman, N. J., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2020.7200 · Cited by 88
Self-citation30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement
Zahr, F. E., Song, H. K., Chadderdon, S. M., Gada, H., Mumtaz, M. A., Byrne, T., Kirshner, M., BAJWA, T. K., Weiss, E. S., Kodali, S., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.10.018 · Cited by 87
Self-citationLettino, M., Mascherbauer, J., Nordaby, M., Ziegler, A., Collet, J., Dérumeaux, G., Hohnloser, S. H., Leclercq, C., O’Neill, D. E., Visseren, F. L. J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac033 · Cited by 87
Chioncel, O. D., Adamo, M., Nikolaou, M., Parissis, J., Mebazaa, A., Yılmaz, M. B., Hassager, C., Moura, B., Bauersachs, J. K., Harjola, V., et al. (2023) · European Journal of Heart Failure · doi:10.1002/ejhf.2918 · Cited by 88
Bartko, P. E., Hülsmann, M., Hung, J., Pávó, N., Levine, R. A., Pîbarot, P., Vahanian, A. S., Stone, G. W., & Goliasch, G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa129 · Cited by 87
“Transcatheter repair and replacement for SVR might allow the detrimental effects of the regurgitant load to be safely reduced and disrupt the vicious circle of valvular-driven HF progression.(20,102,103) In the future, the evolving toolset of devices for SVR may lead to a mechanism-tailored approach that addresses spe…”
BackgroundSelf-citationPulerwitz, T., Khalique, O. K., Leb, J. S., Hahn, R. T., Nazif, T. M., Leon, M. B., George, I., Vahl, T. P., D’Souza, B. M., Bapat, V., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.01.041 · Cited by 86
Secondary Mitral Regurgitation
O’Gara, P. T., & Mack, M. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp1903331 · Cited by 86
Self-citationConsensus Document on Non-Suitability for Transcatheter Mitral Valve Repair by Edge-to-Edge Therapy
Lim, D. S., Herrmann, H. C., Grayburn, P. A., Koulogiannis, K. P., Ailawadi, G., Williams, M. R., Ng, V. G., Chau, K. H.-Y., Sorajja, P., Smith, R. L., et al. (2021) · Structural Heart · doi:10.1080/24748706.2021.1902595 · Cited by 86
Self-citationHiguchi, S., Orban, M., Stolz, L., Karam, N., Praz, F., Kalbacher, D., Ludwig, S., Braun, D., Näbauer, M., Wild, M. G., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.03.050 · Cited by 86
Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair
von Bardeleben, R. S., Rogers, J. H., Mahoney, P. D., Price, M. J., Denti, P., Maisano, F., Rinaldi, M., Rollefson, W. A., MARCO, F. D., Chehab, B., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.05.013 · Cited by 86
Self-citationLeft Ventricular Reverse Remodeling in Heart Failure: Remission to Recovery
Boulet, J., & Mehra, M. R. (2021) · Structural Heart · doi:10.1080/24748706.2021.1954275 · Cited by 85
Secondary mitral regurgitation: pathophysiology, proportionality and prognosis
Chehab, O., Roberts-Thomson, R., Ling, C. N. Y., Marber, M. S., Prendergast, B., Rajani, R., & Redwood, S. R. (2020) · Heart · doi:10.1136/heartjnl-2019-316238 · Cited by 84
NT-proBNP for Risk Prediction in Heart Failure
Vergaro, G., Gentile, F., Meems, L. M. G., Aimo, A., Januzzi, J. L., Richards, M., Lam, C. S. P., Latini, R., Staszewsky, L. I., Anand, I. S., et al. (2021) · JACC Heart Failure · doi:10.1016/j.jchf.2021.05.014 · Cited by 84
“73 m(2) 60 (46-75) 59 (44-75) 59 (40-82) 60 (46-74) 61 (48-77) 63 (47-81) 65 (48-81)”
Advances in transcatheter mitral and tricuspid therapies
Overtchouk, P., Piazza, N., Granada, J. F., Soliman, O. I. I., Prendergast, B., & Modine, T. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01312-3 · Cited by 83
Adamo, M., Pagnesi, M., Ghizzoni, G., Estévez‐Loureiro, R., Raposeiras‐Roubín, S., Tomasoni, D., Stolfo, D., Sinagra, G., Rubbio, A. P., Bedogni, F., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2637 · Cited by 83
Calabrò, P., Gragnano, F., Niccoli, G., Marcucci, R., Zimarino, M., Spaccarotella, C., Renda, G., Patti, G., Andò, G., Moscarella, E., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.054305 · Cited by 81
Rajagopalan, N., Borlaug, B. A., Bailey, A. L., Eckman, P., Guglin, M. E., Hall, S. A., Montgomery, M., Ramani, G. V., & Khazanie, P. (2024) · JACC Heart Failure · doi:10.1016/j.jchf.2024.03.020 · Cited by 81
Transcatheter heart valve interventions: where are we? Where are we going?
Prendergast, B., Baumgartner, H., Delgado, V., Gérard, O., Haude, M., Himmelmänn, A., Iung, B., Leafstedt, M., Lennartz, J., Maisano, F., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy668 · Cited by 79
Patzelt, J., Zhang, W., Sauter, M., Mezger, M., Nording, H., Ulrich, M., Becker, A., Patzelt, T. A. E., Rudolph, V., Eitel, I., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011366 · Cited by 79
Baron, S. J., Wang, K., Arnold, S. V., Magnuson, E. A., Whisenant, B., Brieke, A., Rinaldi, M., Asgar, A. W., Lindenfeld, J., Abraham, W. T., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.043275 · Cited by 72
Self-citationPacker, M., & Grayburn, P. A. (2019) · Circulation · doi:10.1161/circulationaha.119.039612 · Cited by 78
Self-citationPaparella, D., Fattouch, K., Moscarelli, M., Santarpino, G., Nasso, G., Guida, P., Margari, V., Martinelli, L., Coppola, R., Albertini, A., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.11.137 · Cited by 78
Messika–Zeitoun, D., Iung, B., Armoiry, X., Trochu, J., Donal, E., Habib, G., Brochet, É., Thibault, H., Piriou, N., Cormier, B., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.07.021 · Cited by 78
2-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study
Szerlip, M., Spargias, K. S., Makkar, R., Kar, S., Kipperman, R., O’Neill, W. W., Ng, M., Smith, R. L., Fam, N., Rinaldi, M., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.04.001 · Cited by 78
“Moreover, this rate reduced by 81% in the FMR group, compared with 36% in the EXPAND study and 46% in the COAPT study (7,17).”
ResultSelf-citationThe Treatment of Heart Failure with Reduced Ejection Fraction
Berliner, D., Hänselmann, A., & Bauersachs, J. K. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0376 · Cited by 78
Transcatheter Mitral Valve Therapy in the United States: A Report from the STS/ACC TVT Registry
Mack, M. J., Carroll, J. D., Thourani, V. H., Vemulapalli, S., Squiers, J. J., Manandhar, P., Deeb, G. M., Batchelor, W., Herrmann, H. C., Cohen, D. J., et al. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.07.030 · Cited by 77
Self-citationSystolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review
Guigui, S. A., Torres, C. A., Escolar, E., & Mihos, C. G. (2022) · Journal of Thoracic Disease · doi:10.21037/jtd-22-182 · Cited by 77
Association of Pulmonary Hypertension With Clinical Outcomes of Transcatheter Mitral Valve Repair
Al‐Bawardy, R., Vemulapalli, S., Thourani, V. H., Mack, M. J., Dai, D. W. H., Stebbins, A. S., Palacios, I. F., Inglessis, I., Sakhuja, R., Ben–Assa, E., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.4428 · Cited by 77
Self-citationPercutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure
Anker, M. S., Porthun, J., Bonnet, G., Schulze, P. C., Rassaf, T., & Landmesser, U. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.026 · Cited by 76
Perego, C., Sbolli, M., Specchia, C., Fiuzat, M., McCaw, Z. R., Metra, M., Oriecuia, C., Peveri, G., Wei, L., O’Connor, C. M., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.07.005 · Cited by 76
Outcomes Stratified by Adapted Inclusion Criteria After Mitral Edge-to-Edge Repair
Koell, B., Orban, M., Weimann, J., Kassar, M., Karam, N., Neuß, M., Petrescu, A. M., Iliadis, C., Unterhuber, M., Adamo, M., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.10.011 · Cited by 75
Russo, G., Taramasso, M., Pedicino, D., Gennari, M., Gavazzoni, M., Pozzoli, A., Muraru, D., Badano, L. P., Metra, M., & Maisano, F. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2398 · Cited by 76
Adamo, M., Tomasoni, D., Stolz, L., Stocker, T. J., Pancaldi, E., Koell, B., Karam, N., Besler, C., Giannini, C., Sampaio, F., et al. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.01.362 · Cited by 75
Zile, M. R., Borlaug, B. A., Kramer, C. M., Baum, S. J., Litwin, S. E., Menon, V., Ou, Y., Weerakkody, G. J., Hurt, K. C., Kanu, C., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.072679 · Cited by 74
Non-Operating Room Anesthesia: Patient Selection and Special Considerations
Wong, T., Georgiadis, P. L., Urman, R. D., & Tsai, M. H. (2020) · Local and Regional Anesthesia · doi:10.2147/lra.s181458 · Cited by 74
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
Pagnesi, M., Adamo, M., Sama, I. E., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., Ponikowski, P. P., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2276 · Cited by 74
Does the heart transplant have a future?
Fuchs, M., Schibilsky, D., Zeh, W., Berchtold‐Herz, M., Beyersdorf, F., & Siepe, M. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz107 · Cited by 74
“The latest evidence on interventional edge-to-edge repair in this patient cohort indicates that in patients whose condition is stable and in high volume centres, this therapy can lead to survival benefits and symptomatic relief from dyspnoea [23].”
BackgroundPulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation
Ben‐Yehuda, O., Shahim, B., Chen, S., Liu, M., Redfors, B., Hahn, R. T., Asch, F. M., Weissman, N. J., Medvedofsky, D. A., Puri, R., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.609 · Cited by 74
“The COAPT trial design (8) and primary results (9) have been previously published.”
MethodSelf-citationFunctional Mitral Regurgitation Outcome and Grading in Heart Failure With Reduced Ejection Fraction
Benfari, G., Antoine, C., Essayagh, B. A., Batista, R., Maalouf, J. F., Rossi, A., Grigioni, F., Thapa, P. B., Michelena, H. I., & Enriquez-Sarano, M. L. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.05.017 · Cited by 74
Adamo, M., Grasso, C., Capodanno, D., Rubbio, A. P., Scandura, S., Giannini, C., Fiorelli, F., Fiorina, C., Branca, L., Brambilla, N., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.06.015 · Cited by 73
Prediction of Death or HF Hospitalization in Patients With Severe FMR
Shah, N. N., Madhavan, M. V., Gray, W. A., Brener, S. J., Ahmad, Y., Lindenfeld, J. M., Abraham, W. T., Grayburn, P. A., Kar, S., Lim, D. S., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.08.005 · Cited by 73
Self-citationGiustino, G., Overbey, J., Taylor, D., Ailawadi, G., Kirkwood, K., DeRose, J., Gillinov, M. A., Dagenais, F., Mayer, M.-L., Moskowitz, A., et al. (2019) · JACC: Heart Failure · doi:10.1016/j.jchf.2019.03.001 · Cited by 71
“Similarly, in the recently completed COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation) trial, correction of secondary severe MR with transcatheter MVRep compared with no correction reduced the risk of death or HF-rehospitali…”
ResultSelf-citationMitral valve regurgitation: a disease with a wide spectrum of therapeutic options
Forno, B. D., Bonis, M. D., Agricola, E., Melillo, F., Schiavi, D., Castiglioni, A., Montorfano, M., & Alfieri, O. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0395-7 · Cited by 74
(2019) · European Heart Journal · doi:10.1093/eurheartj/ehz828 · Cited by 73
Wild, M. G., Kreidel, F., Hell, M. M., Praz, F., Mach, M., Adam, M., Reineke, D., Ruge, H., Ludwig, S., Conradi, L., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2434 · Cited by 72
Avenatti, E., Mackensen, G. B., El-Tallawi, K. C., Reisman, M., Gruye, L. E., Barker, C. M., & Little, S. H. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2018.12.006 · Cited by 71
Infective endocarditis – A review of current therapy and future challenges
Rezar, R., Lichtenauer, M., Haar, M., Hödl, G., Kern, J. M., Zhou, Z., Wuppinger, T., Kraus, J., Strohmer, B., Hoppe, U. C., et al. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.10.007 · Cited by 71
Bedogni, F., Rubbio, A. P., Grasso, C., Adamo, M., Denti, P., Giordano, A., Tusa, M. B., Bianchi, G., MARCO, F. D., Bartorelli, A. L., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2159 · Cited by 71
Stolz, L., Doldi, P. M., Orban, M., Karam, N., Puscas, T., Wild, M. G., Popescu, A., von Bardeleben, R. S., Iliadis, C., Baldus, S. E., et al. (2022) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2022.10.032 · Cited by 71
Metadata
- Authors
- Stone, G. W., Lindenfeld, J., Abraham, W. T., Kar, S., Lim, D. S., Mishell, J. M., Whisenant, B., Grayburn, P. A., Rinaldi, M., Kapadia, S. R., Rajagopal, V., Sarembock, I. J., Brieke, A., Marx, S. O., Cohen, D. J., Weissman, N. J., & Mack, M. J.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Cedars-Sinai Medical Center (US)
- Cleveland Clinic (US)
- University of Colorado Hospital (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-12-13
- Volume
- 379
- Issue
- 24
- Pages
- 2307-2318
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2889688444
- Cited by
- 3,017
- References
- 23
- Citations by year
- 2026: 253 · 2025: 330 · 2024: 308 · 2023: 372 · 2022: 385 · 2021: 486 · 2020: 453 · 2019: 376 · 2018: 42
- FWCI
- 256.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Abbott
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cardiac Structural Anomalies and Repair
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- transcatheter mitral valve repair, heart failure, functional mitral regurgitation, left ventricular dysfunction, heart failure hospitalization, all-cause mortality, device complications, guideline-directed medical therapy, COAPT trial, transcatheter edge-to-edge repair, mitral valve repair, transcatheter closure devices, transcatheter aortic valve implantation, transcatheter mitral valve replacement
- MeSH terms
- Aged, Aged, 80 and over, Combined Modality Therapy, Female, Heart Failure, Heart Valve Prosthesis, Hospitalization, Humans, Male, Middle Aged, Mitral Valve, Mitral Valve Insufficiency, Prosthesis Failure, Stroke Volume, Treatment Outcome, Ventricular Dysfunction, Left, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate, Intention to Treat Analysis, Percutaneous Coronary Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.